Publications 2025

Behsen AD, Vandsemb EN, Slørdahl TS, Dybkær K, Jakobsen MZ, Kashif M, Lund J, Luong V, Olsnes AM, Waage A, Sponaas AM, Misund K (2025)
T cell phenotype and clonality changes in myeloma patients with short overall survival
JCI Insight, 10 (11)
DOI 10.1172/jci.insight.181096, PubMed 40299757

Publications 2024

Behsen AD, Holien T, Micci F, Rye M, Rasmussen JM, Andersen K, Hess ES, Børset M, Keats J, Våtsveen TK, Misund K (2024)
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy
Sci Rep, 14 (1), 28805
DOI 10.1038/s41598-024-80263-y, PubMed 39567630

Behsen AD, Vandsemb EN, Slørdahl TS, Hjorth-Hansen H, Quist-Paulsen P, Misund K, Sponaas AM, Waage A (2024)
A patient with minimal myeloma treatment who survived for 20 years
Haematologica, 109 (4), 1301-1305
DOI 10.3324/haematol.2023.283563, PubMed 37794808

Jakobsen T, Pløen GG, Behsen AD, Møller HJ, Plesner T, Dybkær K, Andersen MN, Misund K, Kristensen LS (2024)
The Prognostic Potential of circRNAs in Multiple Myeloma: Insights From Whole Bone Marrow and Purified Plasma Cells
J Cell Mol Med, 28 (22), e70215
DOI 10.1111/jcmm.70215, PubMed 39601341

Publications 2021

Michels L, Richter A, Chellappan RK, Røst HI, Behsen A, Wells KH, Leal L, Santana V, Blawid R, da Silva GJ, Cooil SP, Wells JW, Blawid S (2021)
Electronic and structural properties of the natural dyes curcumin, bixin and indigo
RSC Adv, 11 (23), 14169-14177
DOI 10.1039/d0ra08474c, PubMed 35423953